Patients on DOAC have minimal risk of delayed ICH after low energy blunt head trauma
USA: For individuals on direct oral anticoagulants (DOACs), the risk of delayed intracranial hemorrhage (ICH) following low-intensity blunt head trauma is minimal, and the chance of a clinically significant bleed is much lower, says an article published in the Journal of the American College of Surgeons.
Delayed ICH following a negative first head cat scan (CT) is a known consequence of physical trauma, although the risk of this syndrome is unclear. There is a lack of consensus about the necessity for further observation or routine repeat head CT in patients on direct oral anticoagulants due to the possible increased risk and difficulty to assess the degree of anticoagulation. As a result, Thaddeus J. Puzio and colleagues anticipated that patients using DOACs would have a low incidence of delayed ICH following blunt head trauma.
A medical librarian (TH) did an electronic literature search of Embase (Elsevier), MEDLINE (Ovid), and Cochrane Library in June 2020 using a mix of keywords and subject headings. Databases were searched from their establishment till June 2020. The included studies reported on the outcomes of trauma patients over the age of 18 who were undertaking anticoagulants and were monitored after an initial normal head CT. A random-effects model was used in a meta-analysis. The Newcastle-Ottawa Scale (NOS) was used in meta-analyses to assess the quality of nonrandomized research.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.